CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett's esophagus.

Détails

Ressource 1Télécharger: 35006394_BIB_B9E2214CAD9F.pdf (2399.33 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_B9E2214CAD9F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett's esophagus.
Périodique
EJNMMI research
Auteur⸱e⸱s
Marcazzan S., Braz Carvalho M.J., Konrad M., Strangmann J., Tenditnaya A., Baumeister T., Schmid R.M., Wester H.J., Ntziachristos V., Gorpas D., Wang T.C., Schottelius M., Quante M.
ISSN
2191-219X (Print)
ISSN-L
2191-219X
Statut éditorial
Publié
Date de publication
10/01/2022
Peer-reviewed
Oui
Volume
12
Numéro
1
Pages
2
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Near-infrared (NIR) fluorescence imaging has been emerging as a promising strategy to overcome the high number of early esophageal adenocarcinomas missed by white light endoscopy and random biopsy collection. We performed a preclinical assessment of fluorescence imaging and endoscopy using a novel CXCR4-targeted fluorescent peptide ligand in the L2-IL1B mouse model of Barrett's esophagus.
Six L2-IL1B mice with advanced stage of disease (12-16 months old) were injected with the CXCR4-targeted, Sulfo-Cy5-labeled peptide (MK007), and ex vivo wide-field imaging of the whole stomach was performed 4 h after injection. Before ex vivo imaging, fluorescence endoscopy was performed in three L2-IL1B mice (12-14 months old) by a novel imaging system with two L2-IL1B mice used as negative controls.
Ex vivo imaging and endoscopy in L2-IL1B mice showed that the CXCR4-targeted MK007 accumulated mostly in the dysplastic lesions with a mean target-to-background ratio > 2. The detection of the Sulfo-Cy5 signal in dysplastic lesions and its co-localization with CXCR4 stained cells by confocal microscopy further confirmed the imaging results.
This preliminary preclinical study shows that CXCR4-targeted fluorescence endoscopy using MK007 can detect dysplastic lesions in a mouse model of Barrett's esophagus. Further investigations are needed to assess its use in the clinical setting.
Mots-clé
Animal models, Barrett’s esophagus, CXCR4, Dysplasia, Endoscopy, Esophageal cancer, Fluorescence imaging, Molecular imaging, Peptide
Pubmed
Web of science
Open Access
Oui
Création de la notice
17/01/2022 11:08
Dernière modification de la notice
23/11/2022 7:14
Données d'usage